
Improvement of cancer therapy by introducing new concepts is still urgent even though there have been major zzso zzso zzso is well on the way to becoming an established tool in the cancer treatment zzso It seems that a combination of zzso zzso of immune zzso cells and selective targeting of them to tumors and zzso the zzso of immune suppression often induced by the tumor itself are necessary to achieve the therapeutic zzso The zzso zzso zzso was developed in an effort to activate and target the patient's own T cells to their zzso by fusing a zzso zzso zzso that activates T zzso to the zzso zzso of a zzso zzso zzso zzso zzso targets the zzso tumor zzso a zzso zzso zzso protein expressed on many zzso including zzso cell zzso The therapeutic effect is associated with zzso of zzso T zzso The zzso T zzso expand, differentiate to zzso cells, and zzso the zzso The therapeutic efficacy is most likely related to the dual mechanism of tumor cell zzso zzso direct zzso by zzso T zzso of tumor cells expressing the zzso recognized by the zzso zzso of the fusion protein and zzso zzso of zzso eliminating zzso tumor cell zzso zzso zzso has been clinically tested in a range of solid tumors with focus on zzso cell zzso This review looks at the clinical experience with the new zzso and its zzso 

